💨 Abstract

India's drug regulator has revoked its suspension of eye drops developed by Entod Pharmaceuticals, meant to treat presbyopia, following certain conditions. The eye drops, branded as PresVu, contain pilocarpine hydrochloride and are set to debut in June. Pilocarpine, associated with serious side-effects, is typically used to reduce eye pressure and treat glaucoma.

Courtesy: theprint.in